Publications by authors named "Jason Human"

Claim this Profile
D
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's disease.
Jian Jeffrey Chen, Qingyian Liu, Chester Yuan, Vijay Gore, Patricia Lopez, Jason Human

Bioorg Med Chem Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors.
Oleg Epstein, Marian C Bryan, Alan C Cheng, Katayoun Derakhchan, Thomas A Dineen, Jason B Human

J Med Chem· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Design of Potent and Selective CK1γ Inhibitors.
Hongbing Huang, Lisa Acquaviva, Virginia Berry, Howard Bregman, Nagasree Chakka, Jason Human

ACS Med Chem Lett· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency.
Wenyuan Qian, Jian Jeffrey Chen, Jason Human, Toshihiro Aya, Jiawang Zhu

Bioorg Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.
Jian Jeffrey Chen, Thomas Nguyen, Derin C D'Amico, Wenyuan Qian, Jason Human

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of alpha-amidosulfones as potent and selective agonists of CB2: synthesis, SAR, and pharmacokinetic properties.
Isaac E Marx, Erin F DiMauro, Alan Cheng, Renee Emkey, Stephen A Hitchcock, Jason Human

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
Kaustav Biswas, Toshihiro Aya, Wenyuan Qian, Tanya A N Peterkin, Jian Jeffrey Chen, Jason Human

Bioorg Med Chem Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit.
Essa Hu, Andrew Tasker, Ryan D White, Roxanne K Kunz, Jason Human

J Med Chem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
Kaustav Biswas, Aiwen Li, Jian Jeffrey Chen, Derin C D'Amico, Christopher Fotsch, Jason Human

J Med Chem· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity.
Derin C D'Amico, Toshi Aya, Jason Human, Christopher Fotsch, Jian Jeffrey Chen

J Med Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtle factors are important: radical formation and transmetallation in reactions of butyl cuprates with cyclohexyl iodide.
Steven H Bertz, Jason Human, Craig A Ogle, Paul Seagle

Org Biomol Chem· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis